Allergan inc (AGN)
Income statement / Yearly
Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07
Revenues:
Product net sales

7,126

6,197

5,549

5,144

4,819

4,447

4,339

3,879

Other revenues

111

102

97

72

99

56

63

59

Total revenues

7,237

6,300

5,646

5,216

4,919

4,503

4,403

3,938

Operating costs and expenses:
Cost of sales (excludes amortization of intangible assets)

842

795

751

718

722

750

761

673

Selling, general and administrative

2,837

2,519

2,193

2,158

2,017

1,921

1,856

1,680

Research and development

1,191

1,042

977

871

804

706

797

718

Amortization of intangible assets

112

116

90

86

138

146

150

121

Legal settlement

-

-

-

-

609

0

0

-

Impairment of intangible assets and related costs

0

11

22

7

369

0

0

-

Restructuring charges

245

5

1

-0

0

50

41

26

Operating income

2,009

1,809

1,611

1,374

258

928

796

719

Non-operating income (expense):
Interest income

7

6

6

6

7

7

33

65

Interest expense

69

75

63

71

78

76

85

94

Gain on investments, net

-

-

-

-

-

24

0

0

Unrealized (loss) gain on derivative instruments, net

-

-

-

-

-

-

-

-0

Other, net

41

-10

-23

-0

-16

-34

18

-25

Total non-operating income (expense)

-20

-78

-80

-65

-87

-79

-33

-54

Earnings from continuing operations before income taxes

1,989

1,730

1,531

1,309

170

848

762

664

Provision for income taxes

456

458

430

359

165

224

197

177

Earnings from continuing operations

1,532

1,272

1,100

949

-

-

-

487

Discontinued Operations:
Earnings from discontinued operations, net of applicable income tax expense of $6.9 million and $0.5 million for the years ended December 31, 2013 and 2012, respectively

0

14

1

-11

-

-

-

-0

Loss on sale of discontinued operation, net of applicable income tax expense (benefit) of $1.3 million and $(110.3) million for the years ended December 31, 2014 and 2013, respectively

-3

-297

0

0

-

-

-

-1

Discontinued operations

-3

-283

1

-11

-

-

-

-1

Net earnings

1,528

988

1,102

938

4

623

564

485

Net earnings attributable to noncontrolling interest

4

3

3

3

4

2

1

0

Net earnings attributable to Allergan, Inc.

1,524

985

1,098

934

0

621

563

484

Earnings per share attributable to Allergan, Inc. stockholders:
Basic earnings per share attributable to Allergan, Inc. stockholders:
Continuing operations (in dollars per share)

5.13

4.28

3.64

3.11

-

-

-

1.59

Discontinued operations (in dollars per share)

-0.01

-0.96

0.00

-0.04

-

-

-

0.00

Net basic earnings per share attributable to Allergan, Inc. stockholders (in dollars per share)

5.12

3.32

3.64

3.07

0.00

2.05

1.85

1.59

Diluted earnings per share attributable to Allergan, Inc. stockholders:
Continuing operations (in dollars per share)

5.03

4.20

3.57

3.05

-

-

-

1.58

Discontinued operations (in dollars per share)

-0.02

-0.94

0.01

-0.04

-

-

-

-0.01

Net diluted earnings per share attributable to Allergan, Inc. stockholder (in dollars per share)

5.01

3.26

3.58

3.01

0.00

2.03

1.84

1.57